• Mon, January 28, 2019
  • Wed, January 23, 2019
  • Thu, January 24, 2019
  • Fri, January 25, 2019

John Newman Maintained (BLUE) at Strong Buy with Decreased Target to $161 on, Jan 23rd, 2019

John Newman of Canaccord Genuity, Maintained "bluebird bio, Inc." (BLUE) at Strong Buy with Decreased Target from $250 to $161 on, Jan 23rd, 2019.

John has made no other calls on BLUE in the last 4 months.



There are 2 other peers that have a rating on BLUE. Out of the 2 peers that are also analyzing BLUE, 1 agrees with John's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $125 on, Wednesday, December 19th, 2018


This is the rating of the analyst that currently disagrees with John


  • Michael Schmidt of "Leerink Swann" Initiated at Buy and Held Target at $145 on, Wednesday, November 28th, 2018

Like: 👍